For over 30 years, PharmaVentures has acted as advisor on over 1,000 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies world-wide

We have unrivalled strategic insight in the commercialisation and transaction of assets and companies in the pharmaceutical, biotech, medtech and diagnostics sectors. We have been trusted by major corporations, high growth biotechs and emerging companies to provide insight and advice to help these businesses achieve their strategic goals. Operating globally in M&A, licensing, divestments and fundraising, we have the skills and experience to help you drive your business forward.

PharmaVentures attends key conferences and meetings to discuss our services and we also attend events on behalf of our clients, promoting advisory mandates in M&A and licensing across the life science sector. 

How To Meet Us

We often have opportunities that could be transformative to your business, especially with the optimal strategy and best execution.

Our team attending these events are available to speak with you about your own requirements. To book a meeting, email us at:

Upcoming events

24-26 October 2023

CPHI Barcelona

Andrew Guise and Jansen Jacob will be available for 1-1 meetings.


6-8 November 2023


PharmaVentures’ team will be available for 1-1 meetings.


Recent events

20-21 September 2023

23rd Annual Biotech in Europe Forum

Dr Fintan Walton chaired a panel discussion.

19 September 2023

10th Annual HealthTech Investment Forum (HTIF)

Andrew Guise took in a panel discussion and 1-1 meetings.

6 July 2023

ON Helix

Fotis Galiotos took part in 1-1 meetings.

5-8 June 2023

BIO International

PharmaVentures took part in 1-1 meetings.

20-23 March 2023


Jansen Jacob took part in 1-1 meetings.

20-22 March 2023 

BIO-Europe Spring®

PharmaVentures’ team took part in 1-1 meetings.

1-2 March 2023 

16th Annual European Life Science CEO Forum

Adrian Dawkes chaired the Pharma Dealmaker’s Roundtable and took part in 1-1 meetings.

28 February 2023 

4th Annual European HealthTech CEO Forum

Asif Shahinsha took part in the Investor Roundtable and took part in 1-1 meetings.

9-12 January 2023

BIO One-on-One Partnering™ During JPM Week

PharmaVentures’ team took part in 1-1 meetings.

9-11 January 2023

Biotech Showcase™

PharmaVentures’ team attended 1-1 meetings.

5-8 December 2022

Genesis 2022

Ralph Huges presented Trends in Early Stage Deals: Pricing and Market Access and the team took part in 1-1 meetings.

14-17 November 2022


Asif Shahinsha and Andreas ​Katsiamides took part in 1-1 meetings.

1-3 November 2022

CPhI Worldwide

Dr Fintan Walton, CEO, chaired the panel discussion: Transactional Strategies to Access Future Therapeutics and Technologies which included Abbvie, Medicxi, Thermo Fisher and PharmaVentures VP, Jansen Jacob.

24-26 October 2022 


PharmaVentures’ team took part in 1-1 meetings.